|
GB8427125D0
(en)
|
1984-10-26 |
1984-12-05 |
Lundbeck & Co As H |
Organic compounds
|
|
ATE60571T1
(de)
|
1984-12-04 |
1991-02-15 |
Sandoz Ag |
Inden-analoga von mevalonolakton und ihre derivate.
|
|
DK286990D0
(da)
*
|
1990-12-04 |
1990-12-04 |
Lundbeck & Co As H |
Indanderivater
|
|
DK55192D0
(da)
*
|
1992-04-28 |
1992-04-28 |
Lundbeck & Co As H |
1-piperazino-1,2-dihydroindenderivater
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6221335B1
(en)
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
WO1999015524A1
(en)
|
1997-09-23 |
1999-04-01 |
Fujisawa Pharmaceutical Co., Ltd. |
Thiazole derivatives
|
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
|
SE9904850D0
(sv)
|
1999-12-30 |
1999-12-30 |
Pharmacia & Upjohn Ab |
Novel process and intermediates
|
|
PL1658277T3
(pl)
|
2003-08-18 |
2012-10-31 |
H Lundbeck As |
Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek
|
|
RU2366654C2
(ru)
|
2004-06-08 |
2009-09-10 |
ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ |
Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии
|
|
ES2346452T3
(es)
|
2004-06-08 |
2010-10-15 |
Nsab, Filial Af Neurosearch Sweden Ab, Sverige |
Nuevas fenilpiperidinas/piperazinas disustituidas utilizadas como moduladores de la neurotransmision de la dopamina.
|
|
WO2006086985A1
(en)
|
2005-02-16 |
2006-08-24 |
H. Lundbeck A/S |
Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
|
TWI376373B
(en)
|
2005-02-16 |
2012-11-11 |
Lundbeck & Co As H |
Crystalline base of a pharmaceutical compound
|
|
TWI453198B
(zh)
|
2005-02-16 |
2014-09-21 |
Lundbeck & Co As H |
製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
|
|
US7863274B2
(en)
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
|
KR101380190B1
(ko)
|
2005-07-29 |
2014-04-11 |
콘서트 파마슈티컬즈, 인크. |
벤조 〔ｄ〕〔１,３〕―디옥솔 유도체
|
|
PT1954669E
(pt)
|
2005-12-01 |
2015-10-23 |
Auspex Pharmaceuticals Inc |
Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica
|
|
WO2008086158A1
(en)
|
2007-01-04 |
2008-07-17 |
Smithkline Beecham Corporation |
Benzodihydroquinazoline as pi3 kinase inhibitors
|
|
US8198305B2
(en)
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
|
AU2008242703B2
(en)
|
2007-04-19 |
2011-08-18 |
Concert Pharmaceuticals Inc. |
Deuterated morpholinyl compounds
|
|
EP1997479A1
(en)
|
2007-05-31 |
2008-12-03 |
Helm AG |
Stabilized amorphous candesartan cilexetil compositions for oral administration
|
|
US20090062303A1
(en)
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched ziprasidone
|
|
CN102065861B
(zh)
|
2008-05-07 |
2013-10-16 |
H.隆德贝克有限公司 |
反式-4-((1r，3s)-6-氯-3-苯基茚满-1-基)-1，2，2-三甲基哌嗪用于改善认知的用途
|
|
CN102170884A
(zh)
|
2008-10-03 |
2011-08-31 |
H.隆德贝克有限公司 |
口服制剂
|
|
JP2012506904A
(ja)
|
2008-10-28 |
2012-03-22 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
難水溶性成分のためのメソ多孔性材料賦形剤
|
|
US20120071554A1
(en)
|
2008-10-28 |
2012-03-22 |
Liu Julie F |
Deuterated 2-propylpentanoic acid compounds
|
|
TW201102370A
(en)
*
|
2009-07-07 |
2011-01-16 |
Lundbeck & Co As H |
Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine
|
|
US8557994B2
(en)
|
2009-07-27 |
2013-10-15 |
Daljit Singh Dhanoa |
Deuterium-enriched pyridinonecarboxamides and derivatives
|
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
|
KR101149529B1
(ko)
|
2009-09-11 |
2012-05-25 |
한국화학연구원 |
인덴온 유도체 및 이를 포함하는 약학적 조성물
|
|
CN102020522A
(zh)
|
2009-09-21 |
2011-04-20 |
陈松源 |
氘代药物的制备方法和应用
|
|
WO2011047315A1
(en)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
|
WO2011059080A1
(ja)
|
2009-11-16 |
2011-05-19 |
第一三共株式会社 |
同位体置換されたジアミン誘導体
|
|
EP2521711B1
(en)
|
2010-01-07 |
2017-08-16 |
Alkermes Pharma Ireland Limited |
Quaternary ammonium salt prodrugs
|
|
EP2639216B1
(en)
|
2010-11-09 |
2018-07-11 |
Kaneka Corporation |
Halogenated indenones and method for producing optically active indanones or optically active indanols by using same
|
|
US20130331575A1
(en)
*
|
2011-01-07 |
2013-12-12 |
Robert Dancer |
Method for resolution of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine
|
|
WO2012137225A1
(en)
|
2011-04-08 |
2012-10-11 |
Sphaera Pharma Pvt. Ltd |
Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
|
|
DK2720989T3
(en)
|
2011-06-20 |
2016-11-28 |
H Lundbeck As |
Deuterated 1-piperazino-3-phenyl-indanes used to treat schizophrenia
|
|
AU2013326850B2
(en)
|
2012-10-04 |
2017-09-21 |
Inhibikase Therapeutics, Inc. |
Novel compounds, their preparation and their uses
|
|
EP2931731A1
(en)
*
|
2012-12-11 |
2015-10-21 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
AR094054A1
(es)
|
2012-12-19 |
2015-07-08 |
H Lundbeck As |
6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma
|
|
WO2020089147A1
(en)
|
2018-10-29 |
2020-05-07 |
H. Lundbeck A/S |
Amorphous compounds of formula (i) and amorphous compounds of formula (i) salts
|
|
WO2020114853A1
(en)
|
2018-12-03 |
2020-06-11 |
H. Lundbeck A/S |
Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
|